CytomX Therapeutics, Inc.

Knight v. CytomX Therapeutics, Inc., et al., No. 3:20-cv-03432 (N.D. Cal.)

Stock ticker:
CTMX

CytomX has been sued for securities fraud. The suit alleges that the company misrepresented the efficacy of two key drugs. When that information was published on May 13, 2020, CytomX shares dropped 36%. If you have lost money in your CytomX investment, you may be eligible to recover some of those losses. Contact us with the form below.

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.